Mechanisms of Herpesvirus Resistance
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 146
Special Issue Editor
Interests: herpesviruses; poxviruses; DNA tumor viruses; antiviral agents; drug-resistance; 3D culture models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Herpesviruses are common human pathogens, generally causing mild to asymptomatic infections in immunocompetent hosts. However, human herpesvirus infections are more serious when the host has a weak immune system, causing significant morbidity and mortality among different populations of immunocompromised hosts. An important feature of all herpesviruses is their ability to establish lifelong latent infections after a primary infection, remaining dormant. Reactivation of herpesviruses often occurs when the immune system is impaired, causing life-threatening persistent infections that require prolonged treatment. Such prolonged treatment coupled with an impaired immune system provides the perfect selective landscape for the emergence and selection of drug-resistant mutants. Herpesviruses bearing mutations in genes associated with drug resistance can cause severe infections and extreme discomfort and eventually death among immunocompromised patients. Drug resistance is also increasingly being recognized in immunocompetent individuals suffering from herpetic keratitis.
This Special Issue of Viruses will focus on the latest advances in understanding the mechanism of herpesvirus drug resistance for the different classes of anti-herpesvirus drugs, encompassing in vitro, in vivo, and clinical research. We will also delve into the diagnosis of herpesvirus drug resistance as well as the development of new drugs and strategies to manage drug-resistant herpesvirus infections in the clinic. We invite you to share your most insightful primary research work, reviews, and hypotheses on these important topics.
Prof. Dr. Graciela Andrei
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human herpesviruses
- cytomegalovirus
- drug resistance
- antiviral agents
- immunocompromised host
- novel anti-herpesvirus therapies
- DNA polymerase
- terminase
